CD8A and neoplasm: Firstly, while our trajectory and scTCR/BCR-seq sharing analyses support the intra-tumoral differentiation of CD8+ and CD4+ T cells as well as B cells in mTLS, the origin of the T and B cells, whether already in the site of tumor or from the organ, such as tdLNs or blood, is unclear.